These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 2598534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G.
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [Abstract] [Full Text] [Related]

  • 3. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM, Sage JI, Sonsalla PK, Vitagliano D.
    Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507
    [Abstract] [Full Text] [Related]

  • 4. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH, Lees AJ, Stern GM.
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [Abstract] [Full Text] [Related]

  • 5. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M, Miwa H, Kondo T.
    No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758
    [Abstract] [Full Text] [Related]

  • 6. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y.
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [Abstract] [Full Text] [Related]

  • 7. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R, Schulzer M, Mak E, Calne DB, Stoessl AJ.
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The impact of treatment with levodopa on Parkinson's disease.
    Shaw KM, Lees AJ, Stern GM.
    Q J Med; 1980 Apr; 49(195):283-93. PubMed ID: 7465763
    [Abstract] [Full Text] [Related]

  • 10. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
    Miwa H, Mizuno Y.
    No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694
    [Abstract] [Full Text] [Related]

  • 11. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR, Sage JI, Lang AE, Mark MH.
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].
    García de Yébenes J, Mateo D, Pino MA, Cordero M, Pastor M, Chacón J, Morales B, Sánchez V, Mena MA, Giménez Roldán S.
    Neurologia; 1997 Apr; 12(4):145-56. PubMed ID: 9235023
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 16. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV, Sternić NM, Filipović SR, Vojvodić NM, Kostić VS.
    Srp Arh Celok Lek; 1997 Nov; 125(7-8):203-6. PubMed ID: 9304232
    [Abstract] [Full Text] [Related]

  • 19. Clinical aspects of motor fluctuations in Parkinson's disease.
    Poewe WH.
    Neurology; 1994 Jul; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
    [Abstract] [Full Text] [Related]

  • 20. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A, Grau-Veciana JM.
    Med Clin (Barc); 1985 Jun 15; 85(3):88-91. PubMed ID: 4021630
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.